Join
Live feed
·
INSIDERFilingvia Quantisnow
Nuvectis Pharma Inc. logo

Bentsur Ron bought $35,455 worth of shares (3,220 units at $11.01), increasing direct ownership by 0.10% to 3,235,764 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NVCT (Nuvectis Pharma Inc.) and more on Quantisnow.